FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2052619365> ?p ?o ?g. }

• W2052619365 endingPage "161" @default.
• W2052619365 startingPage "157" @default.
• W2052619365 abstract "Background: Concern has been raised regarding the mortality and ethics related to the treatment of patients with end-stage chronic heart failure with chronic intermittent intravenous inotropic agents. We examined whether intermittent inotropic agents combined with oral amiodarone to prevent the proarrhythmic effect of inotropic agents results in better outcomes. Methods: The study included 162 patients with decompensated end-stage chronic heart failure, who could be weaned from an initial 72-hour infusion of intravenous inotropes. Group 1 included 140 patients, who entered a 6-month program of weekly intermittent intravenous inotropic agents plus oral amiodarone, 200 mg twice a day. Group 2 included 22 patients, who were treated with optimal conventional therapy and were hospitalized for administration of intravenous medications as needed. Results: The baseline characteristics of groups 1 versus 2, including New York Heart Association functional class (IV in both groups), admission systolic arterial blood pressure (99 ± 14 vs. 97 ± 13 mm Hg), right atrial pressure (13 ± 6 vs. 14 ± 6 mm Hg), pulmonary capillary wedge pressure (28 ± 7 vs. 31 ± 10 mm Hg), serum sodium (136 ± 7 vs. 139 ± 6 mEq/L) and serum creatinine (1.7 ± 0.8 vs. 1.8 ± 1.8 mg/dL), were similar. The 6-month (51% vs. 18%) and 1-year (36% vs. 9%) survival rates were significantly higher (P = 0.001 for both) in group 1 than in group 2. In addition, patients treated with intermittent intravenous inotropic agents improved their functional and hemodynamic status. Conclusions: Intermittent intravenous inotropic agents combined with prophylactic oral amiodarone seem to improve the outcomes of patients with end-stage chronic heart failure. Further research is warranted to elucidate whether this treatment strategy should be considered as a standard therapy in patients with refractory end-stage heart failure." @default.
• W2052619365 created "2016-06-24" @default.
• W2052619365 creator A5004578083 @default.
• W2052619365 creator A5040297232 @default.
• W2052619365 creator A5045594336 @default.
• W2052619365 creator A5058044822 @default.
• W2052619365 creator A5059203225 @default.
• W2052619365 creator A5082417835 @default.
• W2052619365 creator A5086215062 @default.
• W2052619365 creator A5091794790 @default.
• W2052619365 date "2009-02-01" @default.
• W2052619365 modified "2023-10-16" @default.
• W2052619365 title "Intermittent Inotropic Infusions Combined With Prophylactic Oral Amiodarone for Patients With Decompensated End-stage Heart Failure" @default.
• W2052619365 cites W1975274586 @default.
• W2052619365 cites W1978425946 @default.
• W2052619365 cites W1997780004 @default.
• W2052619365 cites W1997993335 @default.
• W2052619365 cites W1998422782 @default.
• W2052619365 cites W2008896413 @default.
• W2052619365 cites W2011020587 @default.
• W2052619365 cites W2026191697 @default.
• W2052619365 cites W2034733088 @default.
• W2052619365 cites W2037166741 @default.
• W2052619365 cites W2043944140 @default.
• W2052619365 cites W2048592279 @default.
• W2052619365 cites W2058542276 @default.
• W2052619365 cites W2059421744 @default.
• W2052619365 cites W2064500978 @default.
• W2052619365 cites W2071087294 @default.
• W2052619365 cites W2075175982 @default.
• W2052619365 cites W2080720890 @default.
• W2052619365 cites W2087152707 @default.
• W2052619365 cites W2090393028 @default.
• W2052619365 cites W2101809775 @default.
• W2052619365 cites W2104847567 @default.
• W2052619365 cites W2112829244 @default.
• W2052619365 cites W2131912652 @default.
• W2052619365 cites W2142085398 @default.
• W2052619365 cites W2147232992 @default.
• W2052619365 cites W2153334293 @default.
• W2052619365 cites W2331835422 @default.
• W2052619365 cites W3152166083 @default.
• W2052619365 doi "https://doi.org/10.1097/fjc.0b013e31819846cd" @default.
• W2052619365 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19188832" @default.
• W2052619365 hasPublicationYear "2009" @default.
• W2052619365 type Work @default.
• W2052619365 sameAs 2052619365 @default.
• W2052619365 citedByCount "20" @default.
• W2052619365 countsByYear W20526193652012 @default.
• W2052619365 countsByYear W20526193652013 @default.
• W2052619365 countsByYear W20526193652014 @default.
• W2052619365 countsByYear W20526193652015 @default.
• W2052619365 countsByYear W20526193652016 @default.
• W2052619365 countsByYear W20526193652019 @default.
• W2052619365 countsByYear W20526193652020 @default.
• W2052619365 countsByYear W20526193652021 @default.
• W2052619365 crossrefType "journal-article" @default.
• W2052619365 hasAuthorship W2052619365A5004578083 @default.
• W2052619365 hasAuthorship W2052619365A5040297232 @default.
• W2052619365 hasAuthorship W2052619365A5045594336 @default.
• W2052619365 hasAuthorship W2052619365A5058044822 @default.
• W2052619365 hasAuthorship W2052619365A5059203225 @default.
• W2052619365 hasAuthorship W2052619365A5082417835 @default.
• W2052619365 hasAuthorship W2052619365A5086215062 @default.
• W2052619365 hasAuthorship W2052619365A5091794790 @default.
• W2052619365 hasConcept C126322002 @default.
• W2052619365 hasConcept C146556889 @default.
• W2052619365 hasConcept C155710745 @default.
• W2052619365 hasConcept C164705383 @default.
• W2052619365 hasConcept C2777953023 @default.
• W2052619365 hasConcept C2778094803 @default.
• W2052619365 hasConcept C2778198053 @default.
• W2052619365 hasConcept C2779161974 @default.
• W2052619365 hasConcept C2779295919 @default.
• W2052619365 hasConcept C35207712 @default.
• W2052619365 hasConcept C42219234 @default.
• W2052619365 hasConcept C71924100 @default.
• W2052619365 hasConcept C84393581 @default.
• W2052619365 hasConceptScore W2052619365C126322002 @default.
• W2052619365 hasConceptScore W2052619365C146556889 @default.
• W2052619365 hasConceptScore W2052619365C155710745 @default.
• W2052619365 hasConceptScore W2052619365C164705383 @default.
• W2052619365 hasConceptScore W2052619365C2777953023 @default.
• W2052619365 hasConceptScore W2052619365C2778094803 @default.
• W2052619365 hasConceptScore W2052619365C2778198053 @default.
• W2052619365 hasConceptScore W2052619365C2779161974 @default.
• W2052619365 hasConceptScore W2052619365C2779295919 @default.
• W2052619365 hasConceptScore W2052619365C35207712 @default.
• W2052619365 hasConceptScore W2052619365C42219234 @default.
• W2052619365 hasConceptScore W2052619365C71924100 @default.
• W2052619365 hasConceptScore W2052619365C84393581 @default.
• W2052619365 hasIssue "2" @default.
• W2052619365 hasLocation W20526193651 @default.
• W2052619365 hasLocation W20526193652 @default.
• W2052619365 hasOpenAccess W2052619365 @default.
• W2052619365 hasPrimaryLocation W20526193651 @default.
• W2052619365 hasRelatedWork W1544243753 @default.
• W2052619365 hasRelatedWork W2036541689 @default.

• next